Ghost Tree Capital, LLC
- SEC CIK
- 0001595851
- 最新申報
- 2024/11/14
2023 年第 3 季持倉
持倉截至 2023/9/30，2023/11/14 申報。只含多頭部位，變化是跟 2023 年第 2 季比股數。
- 持股檔數
- 58
- 較 2023 年第 2 季 +3
- 總值
- $2.07 億
- 較 2023 年第 2 季 −$7,057 萬 (−25.5%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 330,000 | $1,881 萬 | 9.1% | 00.0% | 不變 | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 80,000 | $928.0 萬 | 4.5% | +60,000+300.0% | 加碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 57,500 | $839.7 萬 | 4.1% | +2,500+4.5% | 加碼 | 歷史 |
| TGTXTG Therapeutics, Inc. | COM | 1,000,000 | $836.0 萬 | 4.0% | +175,000+21.2% | 加碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 85,000 | $795.9 萬 | 3.9% | −15,000−15.0% | 減碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 110,000 | $768.8 萬 | 3.7% | 00.0% | 不變 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 664,132 | $760.4 萬 | 3.7% | +316,700+91.2% | 加碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 140,000 | $713.7 萬 | 3.5% | −140,000−50.0% | 減碼 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 400,000 | $710.8 萬 | 3.4% | +250,000+166.7% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 400,000 | $667.2 萬 | 3.2% | +175,000+77.8% | 加碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 650,000 | $633.8 萬 | 3.1% | +75,000+13.0% | 加碼 | 歷史 |
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 525,000 | $603.8 萬 | 2.9% | +286,775+120.4% | 加碼 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 115,000 | $581.7 萬 | 2.8% | −245,000−68.1% | 減碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 130,000 | $499.1 萬 | 2.4% | +130,000 | 新進 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 40,000 | $484.9 萬 | 2.3% | −45,000−52.9% | 減碼 | 歷史 |
| PMVPPMV Pharmaceuticals, Inc. | COM | 705,881 | $433.4 萬 | 2.1% | +424,900+151.2% | 加碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 275,000 | $421.9 萬 | 2.0% | +35,000+14.6% | 加碼 | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,325,000 | $418.7 萬 | 2.0% | +1,325,000 | 新進 | 歷史 |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 325,000 | $413.4 萬 | 2.0% | +325,000 | 新進 | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 395,000 | $409.6 萬 | 2.0% | +240,750+156.1% | 加碼 | 歷史 |
| RVNCRevance Therapeutics, Inc. | COM | 350,000 | $401.4 萬 | 1.9% | −175,000−33.3% | 減碼 | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 215,000 | $393.7 萬 | 1.9% | −335,000−60.9% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 98,951 | $338.0 萬 | 1.6% | −86,049−46.5% | 減碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 101,443 | $301.7 萬 | 1.5% | +101,443 | 新進 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 200,000 | $290.4 萬 | 1.4% | −150,000−42.9% | 減碼 | 歷史 |
| IMGNImmunoGen, Inc. | COM | 175,000 | $277.7 萬 | 1.3% | +75,000+75.0% | 加碼 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 55,000 | $277.3 萬 | 1.3% | +55,000 | 新進 | 歷史 |
| JBIOJade Biosciences, Inc. | COM | 201,197 | $273.0 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| Morphosys AG617760202 | SPONSORED ADS | 400,000 | $268.8 萬 | 1.3% | +400,000 | 新進 | – |
| CYTKCytokinetics Inc | COM NEW | 90,000 | $265.1 萬 | 1.3% | +90,000 | 新進 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 60,000 | $261.4 萬 | 1.3% | −140,000−70.0% | 減碼 | 歷史 |
| EYPTEyePoint, Inc. | COM NEW | 325,000 | $259.7 萬 | 1.3% | +325,000 | 新進 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 225,000 | $249.1 萬 | 1.2% | −425,000−65.4% | 減碼 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 300,000 | $223.8 萬 | 1.1% | −173−0.1% | 減碼 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 175,000 | $212.8 萬 | 1.0% | −25,000−12.5% | 減碼 | 歷史 |
| KRTXKaruna Therapeutics, Inc. | COM | 12,500 | $211.4 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| SLRNACELYRIN, Inc. | COM | 200,000 | $203.4 萬 | 1.0% | +200,000 | 新進 | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 100,000 | $200.6 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 75,000 | $197.8 萬 | 1.0% | +33,000+78.6% | 加碼 | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 80,000 | $166.7 萬 | 0.8% | +80,000 | 新進 | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 22,500 | $151.1 萬 | 0.7% | +22,500 | 新進 | 歷史 |
| QUREuniQure N.V. | SHS | 215,000 | $144.3 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 75,000 | $134.6 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 150,000 | $134.1 萬 | 0.6% | +150,000 | 新進 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 2,500 | $122.9 萬 | 0.6% | +2,500 | 新進 | 歷史 |
| VTYXVentyx Biosciences, Inc. | COM | 35,000 | $121.6 萬 | 0.6% | +35,000 | 新進 | 歷史 |
| WHWKWhitehawk Therapeutics, Inc. | COM | 250,000 | $121.0 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 100,000 | $96.3 萬 | 0.5% | +100,000 | 新進 | 歷史 |
| BMEABiomea Fusion, Inc. | COM | 65,000 | $89.4 萬 | 0.4% | −125,000−65.8% | 減碼 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 64,000 | $74.8 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 45,000 | $73.3 萬 | 0.4% | −65,000−59.1% | 減碼 | 歷史 |
| INBXInhibrx Biosciences, Inc. | COM | 35,000 | $64.2 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| FUSNFusion Pharmaceuticals Inc. | COM | 243,287 | $63.3 萬 | 0.3% | −169,412−41.0% | 減碼 | 歷史 |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 150,000 | $62.3 萬 | 0.3% | +150,000 | 新進 | 歷史 |
| ETNB89bio, Inc. | COM | 30,000 | $46.3 萬 | 0.2% | +30,000 | 新進 | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 65,000 | $41.5 萬 | 0.2% | 00.0% | 不變 | – |
| Rain Oncology Inc.75082Q105 | COM | 325,000 | $28.0 萬 | 0.1% | 00.0% | 不變 | – |
| MRSNMersana Therapeutics, Inc. | COM | 61,250 | $7.78 萬 | <0.1% | 00.0% | 不變 | 歷史 |
選擇權（11 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | – | $2,191 萬 |
| SRPTSarepta Therapeutics, Inc. | COM | – | $1,818 萬 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | $1,425 萬 | – |
| AKROAkero Therapeutics, Inc. | COM | – | $1,265 萬 |
| APLSApellis Pharmaceuticals, Inc. | COM | – | $703.7 萬 |
| RCKTRocket Pharmaceuticals, Inc. | COM | – | $604.5 萬 |
| SNDXSyndax Pharmaceuticals Inc | COM | $435.6 萬 | – |
| REPLReplimune Group, Inc. | COM | – | $427.8 萬 |
| CBAYCymaBay Therapeutics, Inc. | COM | – | $354.7 萬 |
| IMVTImmunovant, Inc. | COM | $326.3 萬 | – |
| SLRNACELYRIN, Inc. | COM | $203.4 萬 | – |
2023 年第 2 季之後清倉（14 檔）
2023 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2023 年第 2 季股數 | 2023 年第 2 季市值 | 2023 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| APLSApellis Pharmaceuticals, Inc. | COM | 180,000 | $1,640 萬 | 5.9% | 歷史 |
| RETAReata Pharmaceuticals Inc | CL A | 85,000 | $866.7 萬 | 3.1% | 歷史 |
| INCYIncyte Corp | COM | 65,000 | $404.6 萬 | 1.5% | 歷史 |
| ONCBeOne Medicines Ltd. | ADR | 22,500 | $401.2 萬 | 1.4% | 歷史 |
| VIRVir Biotechnology, Inc. | COM | 150,000 | $367.9 萬 | 1.3% | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 75,000 | $149.0 萬 | 0.5% | 歷史 |
| BCRXBiocryst Pharmaceuticals Inc | COM | 200,000 | $140.8 萬 | 0.5% | 歷史 |
| MORFMorphic Holding, Inc. | COM | 20,000 | $114.7 萬 | 0.4% | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 27,578 | $72.3 萬 | 0.3% | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 100,000 | $70.4 萬 | 0.3% | 歷史 |
| PTCTPTC Therapeutics, Inc. | COM | 16,675 | $67.8 萬 | 0.2% | 歷史 |
| REPLReplimune Group, Inc. | COM | 10,865 | $25.2 萬 | 0.1% | 歷史 |
| VNDAVanda Pharmaceuticals Inc. | COM | 31,000 | $20.4 萬 | 0.1% | 歷史 |
| KYNBKyntra Bio, Inc. | COM | 36,500 | $9.86 萬 | <0.1% | 歷史 |